Translations:GLP-1 receptor agonist/1/en: Difference between revisions

From Azupedia
Jump to navigation Jump to search
FuzzyBot (talk | contribs)
Importing a new version from external source
(No difference)

Revision as of 21:59, 5 February 2024

Information about message (contribute)
This message has no documentation. If you know where or how this message is used, you can help other translators by adding documentation to this message.
Message definition (GLP-1 receptor agonist)
{{Drug List/ja|state6=uncollapsed}}
{{Pathnav|Medication|Diabetes medication|frame=1}}
{{Short description|Agonist of the GLP-1 receptor used in the treatment of type 2 diabetes}}
{| class="wikitable sortable" style="width:100%"
|-
!一般名
!先発名
!class="unsortable"| 日本
!創薬/開発
!備考
|-
|[[Dulaglutide/ja]]
|[https://www.lillymedical.jp/ja-jp/trulicity トルリシティ](Trulicity) ([https://www.lillymedical.jp/ja-jp/assets/vaultpdf/565d081131f6d2bb133124f9c7cf107ef88de13b8b849a371c319d39b60caff9/トルリシティ(デュラグルチド)電子化された添付文書%20%7C%20医療関係者向け%20–%20日本イーライリリー株式会社 PI]) ([https://www.lillymedical.jp/ja-jp/assets/vaultpdf/cbb6477fcf44dc48299a00752139241dd2233803167c2977c7307fc27d85baca/トルリシティ(デュラグルチド)インタビューフォーム%20%7C%20医療関係者向け%20–%20日本イーライリリー株式会社 IF])
|販売
|[[Eli Lilly and Company]]
|
|-
|}
Medication > Diabetes medication > GLP-1 receptor agonist/1/en